Chemotherapy Induced Pain Global Clinical Trials Review, H1 ...Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 outlines clinical trials in Chemotherapy Induced Pain

SAMPLE

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

GDHC2044CTIDB / Published MAR 2014

© GlobalData. This report is a licensed product and is not to be photocopied

Page 1

Chemotherapy Induced Pain Global

Clinical Trials Review, H1, 2014

Reference Code: GDHC2044CTIDB

Publication Date: MAR 2014

SAMPLE




Page 2

Table of Contents

Table of Contents ............................................................................................................................................................................... 2

List of Tables .................................................................................................................................................................................. 3

List of Figures ................................................................................................................................................................................. 4

Introduction ......................................................................................................................................................................................... 5

Chemotherapy Induced Pain .......................................................................................................................................................... 5

Report Guidance ............................................................................................................................................................................. 5

Clinical Trials by Region ..................................................................................................................................................................... 6

Clinical Trials and Average Enrollment by Country ......................................................................................................................... 7

Top Countries Contributing to Clinical Trials in Asia-Pacific ........................................................................................................ 9

Top Countries Contributing to Clinical Trials in Europe ............................................................................................................. 10

Top Countries Contributing to Clinical Trials in North America .................................................................................................. 11

Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Pain to Oncology Clinical Trials .......................................... 12

Clinical Trials by Phase in G7 Countries .......................................................................................................................................... 13

Clinical Trials in G7 Countries by Trial Status .................................................................................................................................. 14

Clinical Trials by Phase .................................................................................................................................................................... 15

In Progress Trials by Phase .......................................................................................................................................................... 16

Clinical Trials by Trial Status ............................................................................................................................................................ 17

Subjects Recruited Over a Period of Time ....................................................................................................................................... 18

Clinical Trials by Sponsor Type ........................................................................................................................................................ 19

Prominent Sponsors ......................................................................................................................................................................... 20

Top Companies Participating in Chemotherapy Induced Pain Therapeutics Clinical Trials .......................................................... 21

Prominent Drugs .............................................................................................................................................................................. 22

Clinical Trial Profiles ......................................................................................................................................................................... 23

Clinical Trial Overview of Top Companies .................................................................................................................................... 23

NEMA Research Inc. ................................................................................................................................................................. 23

Clinical Trial Overview of NEMA Research Inc. ........................................................................................................................ 23

CK Life Sciences Int'l., (Holdings) Inc. ...................................................................................................................................... 23

Clinical Trial Overview of CK Life Sciences Int'l., (Holdings) Inc. .............................................................................................. 23

Amgen Inc. ................................................................................................................................................................................ 23

Clinical Trial Overview of Amgen Inc. ........................................................................................................................................ 23

Clinical Trial Overview of Top Institutes / Government ................................................................................................................. 24

The University of Texas M. D. Anderson Cancer Center........................................................................................................... 24

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center .................................................................. 24

University of the Sunshine Coast .............................................................................................................................................. 25

Clinical Trial Overview of University of the Sunshine Coast ...................................................................................................... 25

Danish University of Pharmaceutical Sciences ......................................................................................................................... 26

Clinical Trial Overview of Danish University of Pharmaceutical Sciences ................................................................................. 26

The Royal Marsden NHS Foundation Trust .............................................................................................................................. 27

Clinical Trial Overview of The Royal Marsden NHS Foundation Trust ...................................................................................... 27

New Mexico Cancer Care Alliance ............................................................................................................................................ 28

Clinical Trial Overview of New Mexico Cancer Care Alliance .................................................................................................... 28

Virginia Commonwealth University ............................................................................................................................................ 29

Clinical Trial Overview of Virginia Commonwealth University ................................................................................................... 29

Capital District Health Authority, Canada .................................................................................................................................. 30

Clinical Trial Overview of Capital District Health Authority, Canada .......................................................................................... 30

SAMPLE




Page 3

Massachusetts General Hospital ............................................................................................................................................... 31

Clinical Trial Overview of Massachusetts General Hospital ...................................................................................................... 31

Five Key Clinical Profiles .................................................................................................................................................................. 32

Appendix .......................................................................................................................................................................................... 54

Abbreviations ................................................................................................................................................................................ 54

Definitions ..................................................................................................................................................................................... 54

Research Methodology ................................................................................................................................................................. 55

Secondary Research .................................................................................................................................................................... 55

About GlobalData ......................................................................................................................................................................... 56

Disclaimer ..................................................................................................................................................................................... 56

Source .......................................................................................................................................................................................... 56

List of Tables

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region, 2014* ........................................................................ 6

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* ...................... 7

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* .......................................... 8

Chemotherapy Induced Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* .......................................................... 9

Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014* ............................................................... 10

Chemotherapy Induced Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* .................................................... 11

Proportion of Chemotherapy Induced Pain to Oncology Clinical Trials, G7 Countries (%), 2014* ................................................... 12

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* ............................................................. 13

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* ..................................................... 14

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Phase, 2014* ........................................................................ 15

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* ..................................................... 16

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* ................................................................ 17

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 ........................ 18

Chemotherapy Induced Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* ................................................ 19

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* ................................................................ 20

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* ............................................. 21

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* .................. 22

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by NEMA Research Inc., 2014* .............. 23

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by CK Life Sciences Int'l., (Holdings) Inc.,

2014* ................................................................................................................................................................................................ 23

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*.............................. 23

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson

Cancer Center, 2014* ....................................................................................................................................................................... 24

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Sunshine Coast, 2014*

......................................................................................................................................................................................................... 25

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish University of Pharmaceutical

Sciences, 2014* ............................................................................................................................................................................... 26

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Marsden NHS Foundation

Trust, 2014* ...................................................................................................................................................................................... 27

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by New Mexico Cancer Care Alliance,

2014* ................................................................................................................................................................................................ 28

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University,

2014* ................................................................................................................................................................................................ 29

SAMPLE




Page 4

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority,

Canada, 2014* ................................................................................................................................................................................. 30

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*

......................................................................................................................................................................................................... 31

List of Figures

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* .................................................................. 6

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* ...................... 7

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* .......................................... 8

Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* ........................................................ 10

Chemotherapy Induced Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* ............................................. 11

Proportion of Chemotherapy Induced Pain to Oncology Clinical Trials, G7 Countries (%), 2014* ................................................... 12

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* ............................................................. 13

Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* ..................................................... 14

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* ................................................................. 15

Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* ................................................................................................... 16

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* ................................................................ 17

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 ........................ 18

Chemotherapy Induced Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* ......................................... 19

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* ............................................................... 20

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* ............................................ 21

Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* ................. 22

GlobalData Methodology .................................................................................................................................................................. 55

SAMPLE




Page 5

Introduction

Chemotherapy Induced Pain

Chemotherapy induced pain is most often a form of nerve pain. It can cause peripheral neuropathy (painful numbness of the extremities), or paresthesia (numbness and tingling of hands, feet or any extremity of the body).

Report Guidance

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 outlines clinical trials in Chemotherapy Induced

Pain. The prominent features of this report are -

1. Comprehensive data related to Chemotherapy Induced Pain clinical trials by region, country, phase, and

recruitment status

2. Clinical trials conducted by key Companies and Institutes. The selection of the sponsors is based on the total

number of Chemotherapy Induced Pain clinical trials conducted

3. Prominent drugs are provided based on number of ongoing clinical trials

4. The trials compiled in this report are from clinical trial registries, conferences, journals etc

SAMPLE




Page 6

Clinical Trials by Region

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region (%), 2014*

Source: GlobalData’s Pharma eTrack Clinical Trials Database

(*)Trials are taken for a time period of 1982 - 2014

2014 trials are taken as of March 2014

Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region, 2014*

World Zones Number of Clinical Trials




SAMPLE




Page 9

Top Countries Contributing to Clinical Trials in Asia-Pacific

Chemotherapy Induced Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*

Country Name Number of Clinical Trials




SAMPLE




Page 10

Top Countries Contributing to Clinical Trials in Europe

Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*




Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014*

Country Name Number of Clinical Trials




SAMPLE




Page 23

Clinical Trial Profiles

Clinical Trial Overview of Top Companies

NEMA Research Inc.

Clinical Trial Overview of NEMA Research Inc.

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by NEMA Research Inc., 2014*

Trial Title Stage of Development Status




CK Life Sciences Int'l., (Holdings) Inc.

Clinical Trial Overview of CK Life Sciences Int'l., (Holdings) Inc.

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by CK Life Sciences Int'l.,

(Holdings) Inc., 2014*





Amgen Inc.

Clinical Trial Overview of Amgen Inc.

Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*





SAMPLE




Page 54

Appendix

Abbreviations

BRIC: Brazil, Russia, India and China

NCI: National Cancer Institute

Definitions

PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the

side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy

participants and/or patients.

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular

indication or indications in patients with the disease or condition under study and to determine the common short-term

side effects and risks.

PHASE III TRIALS: Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness

of the drug has been obtained, and were intended to gather additional information to evaluate the overall benefit-risk

relationship of the drug and provide an adequate basis for physician labeling.

PHASE IV TRIALS: Post-marketing studies to delineate additional information including the drug's risks, benefits,

and optimal use.

TRIAL STATUS: Indicates the current stage of a trial, whether it is planned, ongoing, or completed. Possible values

include:

Trial in Progress: This is inclusive of;

Planned: participants were not yet being recruited or enrolled

Recruiting: participants were currently being recruited and enrolled

Enrolling by invitation: participants were being (or will be) selected from a predetermined population

Active, not recruiting: study is ongoing (i.e., patients were being treated or examined), but enrollment has

completed

Completed: the study has concluded normally; participants were no longer being examined or treated (i.e.,

last patient's last visit has occurred)

Suspended: recruiting or enrolling participants has halted prematurely but potentially will resume

Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants were

no longer being examined or treated

Withdrawn: study halted prematurely, prior to enrollment of first participant

SUBJECTS RECRUITED: The number of patients so enrolled for the trial in concern, to be analyzed.

UNACCOMPLISHED TRIALS: The category comprising of the terminated, withdrawn and suspended trials.

SAMPLE




Page 55

Research Methodology

GlobalData dedicated Research and Analysis Teams consists of experienced professionals with a pedigree in

marketing, market research and consulting in the pharmaceutical industry with advanced statistical expertise.

GlobalData adheres to the Codes of Practice of the Market Research Society (www.mrs.org.uk) and the Society of

Competitive Intelligence Professionals (www.scip.org).

All GlobalData databases were continuously updated and revised. The following research methodology is followed for

all databases and reports.

GlobalData Methodology

Data extraction from Pharma eTrack

Data Analysis

Self QC

Quality check by QC Lead

Submission of the Report

Data Validation

Source: GlobalData

Secondary Research

The research process begins with exhaustive secondary research on internal and external sources being carried out

to source qualitative and quantitative information relating to each market.

The secondary research sources that were typically referred to include, but were not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC Filings;

Industry trade journals, scientific journals and other technical literature;

Internal and external proprietary databases;

Relevant patent and regulatory databases;

National government documents, statistical databases and market reports;

Procedure registries; and

News articles, press releases and web-casts specific to the companies operating in the market.

http://www.scip.org/

SAMPLE




Page 56

About GlobalData

We hope that the data and analysis in this brief will help you make informed and imaginative business decisions. If

you have further requirements, GlobalData consulting team may be able to help you. GlobalData offers Tailor made

analytical and advisory services to drive your key strategic decisions.

Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,

electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher,

GlobalData.

Source

http://www.cancer.org/acs/groups/content/@nho/documents/document/globalfactsandfigures2007rev2p.pdf

http://clinicaltrials.gov/

http://www.cancer.org/

http://www.asco.org/

http://www.pharmaetrack.com/

http://www.medpedia.com/

https://www.goldbamboo.com/pictures-t1192.html

http://www.clinicalconnection.com/

http://www.trialscentral.org/

http://www.thefreelibrary.com/

http://dailymed.nlm.nih.gov/dailymed/about.cfm

http://www.nextbio.com/b/nextbio.nb

http://www.controlled-trials.com/isrctn/search.html

http://www.anzctr.org.au/trialSearch.aspx

http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=72377

https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=search&action=input&language=E

http://www.cancer.org/acs/groups/content/@nho/documents/document/globalfactsandfigures2007rev2p.pdf

http://clinicaltrials.gov/

http://www.cancer.org/

http://www.asco.org/

http://www.pharmaetrack.com/

http://www.medpedia.com/

https://www.goldbamboo.com/pictures-t1192.html

http://www.clinicalconnection.com/

http://www.trialscentral.org/

http://www.thefreelibrary.com/

http://dailymed.nlm.nih.gov/dailymed/about.cfm

http://www.nextbio.com/b/nextbio.nb

http://www.controlled-trials.com/isrctn/search.html

http://www.anzctr.org.au/trialSearch.aspx

http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=72377

https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=search&action=input&language=E

Documents

Chemotherapy Induced Pain Global Clinical Trials Review, H1 ...Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 outlines clinical trials in Chemotherapy Induced Pain